Clinical Trials Browser

INDUSTRY × codrituzumab × Gastrointestinal × Clear all

NCT01507168 2020-04-03

A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00976170 2014-10-03

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular